Skip to content

Wednesday, December 25, 2024

Latest:

You didn’t meet your goals for 2024. Now what?
Understanding the cascade of molecular events leading to Rett syndrome
The need for language inclusivity in clinical research
Caring for your feet with a diabetes diagnosis
Mapping functional relations among proteins and genes helps illuminate their role in cancer

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

Pfizer’s bivalent RSVpreF (Abrysvo)

A young person about to get a shot in their arm

Policywise

Unlocking the Secrets of Maternal RSV Immunization: What Every Parent Should Know

November 10, 2023 Abrysvo, maternal health, maternal immunization, Pfizer’s bivalent RSVpreF (Abrysvo), pregnant, Respiratory Syncytial Virus (RSV), RSV

On May 18, 2023, the FDA voted to approve Pfizer’s bivalent RSVpreF (Abrysvo) vaccine for pregnant women to protect their newborns against respiratory syncytial virus

From the Labs: Image of the Month

From the Labs: Humans are complex genetic mosaics.